Atlas Trials

Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions

Clinical trial NCT04411953 · COMPLETED

Trial details

NCT number
NCT04411953
Sponsor
Cycle Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2019-11-15
Primary completion
2019-12-19
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.